Compare PSTG & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSTG | TEVA |
|---|---|---|
| Founded | 2009 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.4B | 30.2B |
| IPO Year | 2015 | N/A |
| Metric | PSTG | TEVA |
|---|---|---|
| Price | $70.22 | $30.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 9 |
| Target Price | ★ $92.58 | $29.78 |
| AVG Volume (30 Days) | 5.5M | ★ 10.6M |
| Earning Date | 12-02-2025 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.15 | N/A |
| EPS | 0.38 | ★ 0.62 |
| Revenue | $3,483,782,000.00 | ★ $16,776,000,000.00 |
| Revenue This Year | $16.50 | $4.74 |
| Revenue Next Year | $15.25 | $0.48 |
| P/E Ratio | $187.79 | ★ $48.27 |
| Revenue Growth | ★ 13.18 | 0.02 |
| 52 Week Low | $34.51 | $12.47 |
| 52 Week High | $100.59 | $30.20 |
| Indicator | PSTG | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 38.64 | 80.85 |
| Support Level | $69.88 | $28.00 |
| Resistance Level | $76.39 | $30.20 |
| Average True Range (ATR) | 4.16 | 0.66 |
| MACD | -0.71 | 0.16 |
| Stochastic Oscillator | 7.01 | 95.32 |
Pure Storage Inc is a U.S.-based company that provides an enterprise data storage platform that transforms business through a dramatic increase in performance and reduction in complexity and costs. It generates revenue from two sources: product revenue, which includes the sale of integrated storage hardware and embedded operating system software; and subscription services revenue, which includes Evergreen Storage subscriptions, a unified subscription that includes Pure as-a-Service, Cloud Block Store, and Portworx. Subscription services revenue also includes professional services offerings such as installation and implementation consulting services.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.